Skip to content
Pharma Observatory a Scientist.com platform

Condition (MeSH)

Trigeminal Nerve Injuries

ClinicalTrials.gov lists 18 trials for Trigeminal Nerve Injuries or a narrower condition beneath it.

MeSH D061221 Stomatognathic Diseases C07 C10 C26
Email me this page as a PDF

Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Phase 1 Phase 1 1 Phase 2 Phase 2 1 Phase 3 Phase 3 1 Phase 4 Phase 4 1 Not applicable Not applicable 9 Observational Observational 5 Phase 1 Phase 1 1 Phase 2 Phase 2 1 Phase 3 Phase 3 1 Phase 4 Phase 4 1 Not applicable Not applicable 9 Observational Observational 5

Trials per phase

5 of the 18 trials are tagged with Trigeminal Nerve Injuries itself; the rest are tagged with a narrower condition beneath it.

Get the Trigeminal Nerve Injuries report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

When did Trigeminal Nerve Injuries trials start? (9)

Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.

Trials over time, by phase

  • Phase 1
  • Phase 2
  • Phase 3
  • Phase 4
  • Not applicable
  • Observational

Top of scale: 4

2012: 1 trials (Not applicable 1) 2015: 1 trials (Observational 1) 2016: 2 trials (Observational 1, Not applicable 1) 2019: 4 trials (Observational 2, Phase 4 1, Phase 3 1) 2021: 4 trials (Not applicable 4) 2022: 1 trials (Phase 2 1) 2023: 1 trials (Not applicable 1) 2024: 3 trials (Not applicable 2, Phase 1 1)

Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.

Trials started per year
Year Trials started
2026 (partial year) 1
2024 3
2023 1
2022 1
2021 4
2019 4
2016 2
2015 1
2012 1

No forecast is made for this condition: it averages 1.4 trial starts a year over the five years to September, under the 5 a year the method needs.

Recruitment duration, a model prediction: 1 trial still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.

What phase are Trigeminal Nerve Injuries trials in? (6)

Shown in this order: phase order.

Show the trials by phase as a table
Trials by phase
Phase Trials
Phase 1 1
Phase 2 1
Phase 3 1
Phase 4 1
Not applicable 9
Observational 5

How many Trigeminal Nerve Injuries trials are recruiting? (4)

Shown in this order: the order a trial moves through, from not yet recruiting to unknown.

Trials by recruitment status
Status Trials
Not yet recruiting 1
Completed 10
Terminated 1
Unknown status 6

Status as registered on ClinicalTrials.gov. Each trial is counted once.

Which drugs are being tested for Trigeminal Nerve Injuries? (1)

Shown in this order: most trials first. One row per drug, matched to a single molecule under all its names, ranked by number of trials.

Drugs tested
Drug Trials
Platelet Rich Fibrin 1

Interventions as named in the registry (7)

Shown in this order: most trials first.

Interventions as named in the registry
Drug Trials
BOTOX®, Allergan 1
Low Level Laser Therapy 1
Observational 1
Erenumab PFS 1
Transcranial Magnetic Stimulation 1

These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.

Which publications cover Trigeminal Nerve Injuries? (106)

Shown in this order: major-topic papers first, then newest, then most linked to trials.

Sub-conditions in MeSH (2)

MeSH descendants one level down with at least one trial, most trials first.

Not on this page

Not measured: delivery record.

Checked, with nothing recorded for this condition: lead sponsors, serious adverse events in this condition's trials, prevalence, and rare-disease identity.

Browse all condition evidence pages